Research Coordination Network for Neuroimaging of Social and Affective Disorders Mark Nedelman
by user
Comments
Transcript
Research Coordination Network for Neuroimaging of Social and Affective Disorders Mark Nedelman
Research Coordination Network for Neuroimaging of Social and Affective Disorders Mark Nedelman Mr. Nedelman earned his Bachelor’s and Masters Degree at the University of Cincinnati (Cincinnati, OH) ) and his MBA from Northeastern University (Boston, MA). Mark Nedelman, MS, MBA, is Executive Vice-President of Biomedical Research Models and President of Ekam Imaging, Inc.. Both are nonclinical contract research organizations (CRO) specializing in providing drug discovery services to the biomedical industries. Ekam is a spin-out of the Center for Translational Neuroimaging at Northeastern University and BRM of the University of Massachusetts Medical School. Mark started his drug development career in the nuclear medicine research laboratory at Massachusetts General Hospital in Boston from 1983-87. From there, he was recruited to start and head the Preclinical Pharmacology efforts at Centocor, Inc. in Malvern, PA where he was an Associate Director from 1987-1996 playing key roles in leading the preclinical development and approval of a number first-in-class drugs. In 1996 je joined the CRO industry to help set strategy and develop new specialty services unique (at the time) to the contract industry. He held a number of leadership positions within Charles River Laboratories including being its Senior Director of Pharmacology, Surgery and Toxicology from 2000-2003 and then General Manager of a multi-site business unit, which he established, Interventional and Surgical Services from 2003-2006. From 2007-2010 he was a drug development consultant to a number of biotechnology start-ups as well as being Senior Director of Business Development at SelectX Pharmaceuticals. In 2010 he was asked to become President of Ekam and through a management agreement with BRM, became it’s EVP. His accomplishments over 25 years in the industry includes one patent, over 100 abstracts and invited presentations, more than 35 original, peer-reviewed publications and three book chapters covering the fields of cardiology, oncology, imaging, infectious diseases and inflammation. Mr. Nedelman’s Publications may be found at: https://scholar.google.com/scholar?q=mark+nedelman&btnG=&hl=en&as_sdt=0%2C22 Lab web site: http://www.ekamimaging.com/ Contact Information: EKAM Imaging Corporate Headquarters 263 Huntington Ave, Suite 346 Boston,MA 02115 (617) 281-5499 Northeastern University